Nabriva Therapeutics AG

(NBRV)

By |

Profile

Nabriva Therapeutics AG is a clinical-stage biopharmaceutical company. It researches and develops novel antibiotics to treat serious infections. It has a focus on the pleuromutilin class of antibiotics. Its product includes lefamulin.

Contact Information

Website: www.nabriva.com
Main Phone: +43 1740930
Address: Leberstrasse 20
City / Town: Vienna
Country: AUT
Postal Code: 1110

Issuer Information

Exchange: NGS
Employees: 52
$ 4.10 $ 0.04 (0.95%)
Last Price 4.10 Change $ 0.04 Change % 0.95 Tick N/A
Bid 3.12 Bid Size 100.00 Ask 6.00 Ask Size 400.00
Open 4.08 High 4.16 Low 4.08 Prev Close 4.06
Last Trade Volume 7,274 52 Wk Hi 10.11 52 Wk Low 3.52
Market Cap 87.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 21,308,980.00 EPS (TTM) -1.45 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 22 22 22 22
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 17 17 17 17
Standard Deviation 3.56 3.56 3.56 3.56
Date of Most Recent Estimate 08/09/16 08/09/16 05/10/16 08/09/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 3 3
Moderate Buy 2 2 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.5 1.5 1.4 1.4